ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Korppi, M
Right arrow Articles by Remes, K
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Korppi, M
Right arrow Articles by Remes, K
Eur Respir J 1995; 8: 1318-1320
Copyright © ERS Journals Ltd 1995


Original Articles

Preventive therapy for asthma in children; a 9-year experience in eastern Finland

M Korppi, L Kuikka, and K Remes

The long-term treatment modalities of bronchial asthma were studied in children from a defined Finnish population from 1985 to 1993, with special reference to changes during the study period. The data on maintenance drugs in children with asthma from five years (1985, 1987, 1989, 1991 and 1993) were retrospectively retrieved from the computerized registers. The reliability of the data for the diagnosis and basic treatment of asthma was checked by one of the authors, who compared the data with the patient cards from the hospital. The number of children with doctor-diagnosed asthma increased continuously during the surveillance period. The proportion of children receiving preventive medication increased concomitantly; this increase was most pronounced between 1987 and 1989. The most common preventive drug was sodium cromoglycate; its use increased from 14% in 1985 to 58% in 1993. The use of inhaled steroids remained stable at 17-19% in all surveillance years. Our treatment policy is in accordance with the international consensus statement published in 1989; however, the change towards preventive medication occurred before its publication.


This article has been cited by other articles:


Home page
Eur Respir JHome page
K. Korhonen, T.M. Reijonen, K. Malmstrom, T. Klaukka, K. Remes, and M. Korppi
Hospitalization trends for paediatric asthma in eastern Finland: a 10-yr survey
Eur. Respir. J., June 1, 2002; 19(6): 1035 - 1039.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
S. Kannisto, M. Korppi, K. Remes, and R. Voutilainen
Serum Dehydroepiandrosterone Sulfate Concentration as an Indicator of Adrenocortical Suppression in Asthmatic Children Treated with Inhaled Steroids
J. Clin. Endocrinol. Metab., October 1, 2001; 86(10): 4908 - 4912.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
S. Kannisto, M. Korppi, K. Remes, and R. Voutilainen
Adrenal Suppression, Evaluated by a Low Dose Adrenocorticotropin Test, and Growth in Asthmatic Children Treated with Inhaled Steroids
J. Clin. Endocrinol. Metab., February 1, 2000; 85(2): 652 - 657.
[Abstract] [Full Text]


Home page
BMJHome page
J O Warner
Author's reply
BMJ, December 16, 1995; 311(7020): 1645a - 1645.
[Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1995 by the European Respiratory Society.